Suchergebnisse - (Person:"Zhou, Zhiguang")

PubPharm (8)

1

Diabetes knowledge, attitudes and practices among Chinese primary care physicians: A cross-sectional study

enthalten in: ResearchSquare.com | 2024

von Pi, L. | He, B. | Fei, D. | +2

2

Role of E3 ubiquitin ligases and deubiquitinating enzymes in SARS-CoV-2 infection

enthalten in: Frontiers in cellular and infection microbiology | 2023

von Zhao, M. | Zhang, M. | Yang, Z. | +3

3

Fulminant type 1 diabetes after COVID-19 vaccination

enthalten in: Diabetes & metabolism | 2022

von Tang, X. | He, B. | Liu, Z. | +2

CommentIn: Diabetes Metab. 2022 Jul;48(4):101338. - PMID 35278678

4

Case Report : Subacute thyroiditis after receiving inactivated SARS-CoV-2 vaccine (BBIBP-CorV)

enthalten in: Frontiers in medicine | 2022

von Pi, L. | Lin, J. | Zheng, Y. | +2

5

Reply to "Novaferon, treatment in COVID-19 patients"

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2021

von Zheng, F. | Zhou, Y. | Zhou, Z. | +21

CommentOn: Int J Infect Dis. 2021 Feb;103:297. - PMID 33248244

6

A Novel Protein Drug, Novaferon, as the Potential Antiviral Drug for COVID-19

enthalten in: bioRxiv.org | 2020

von Zheng, F. | Zhou, Y. | Zhou, Z. | +21

7

SARS-CoV-2 clearance in COVID-19 patients with Novaferon treatment : A randomized, open-label, parallel-group trial

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2020

von Zheng, F. | Zhou, Y. | Zhou, Z. | +21

CommentIn: Int J Infect Dis. 2021 Feb;103:297. - PMID 33248244

8

Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?

enthalten in: Journal of autoimmunity | 2020

von Liu, B. | Li, M. | Zhou, Z. | +2

1
[1]